A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes.
- Conditions
- Diabetes Mellitus, Non-Insulin-Dependent
- Registration Number
- NCT00035542
- Lead Sponsor
- Bristol-Myers Squibb
- Brief Summary
The purpose of this clinical research study is to see if Glucovance, a medication currently approved for use in adults with type 2 diabetes, can control type 2 diabetes safely and effectively in children 9 to 16 years of age.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (50)
Childrens's Health System/Dept of PED/Diabetes/Endoncrinology
🇺🇸Birmingham, Alabama, United States
Advanced Clinical Therapeutics
🇺🇸Tucson, Arizona, United States
Hazan, Lydie
🇺🇸Beverly Hills, California, United States
Bautista Research & Medical Center
🇺🇸Fresno, California, United States
Health Care Link, Inc
🇺🇸La Jolla, California, United States
Neufeld Medical Group
🇺🇸Los Angeles, California, United States
National Institute Of Clinical Research
🇺🇸Los Angeles, California, United States
Pasadena Pediatric Endocrinology Diabetes
🇺🇸Pasadena, California, United States
A.R.I. Clinical Trials
🇺🇸Redondo Beach, California, United States
Sutter Institute For Medical Research
🇺🇸Sacramento, California, United States
Scroll for more (40 remaining)Childrens's Health System/Dept of PED/Diabetes/Endoncrinology🇺🇸Birmingham, Alabama, United States